Major pharmaceutical company – DNA-HIVE

Major pharmaceutical company

DNAHIVE was awarded a contract to assess the trends in various cancer treatment modalities among elderly patients in the USA and to evaluate short term complications and long term survival after treatments. Resections, ablations, radiations, concurrent chemoradiation and systemic chemotherapy treatment modalities will be investigated in this study.